Trial intelligence / Profile preview

VISTA study of prediction model-guided anticoagulant duration after unprovoked venous thromboembolism

NL-OMON41715Active, not recruiting

Sponsor
University Medical Center Utrecht
Start
Aug 2011
Countries
1
01

Overview

Randomised, open-label trial in venous thromboembolism (VTE), deep vein thrombosis (DVT) and pulmonary embolism (PE) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Incidence of recurrent venous thromboembolism. Started Aug 2011; status: active, not recruiting.

02

Conditions

venous thromboembolism (VTE)deep vein thrombosis (DVT)pulmonary embolism (PE)

Beyond the preview

Go deeper on NL-OMON41715.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON41715.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call